Prostate Cancer Researchers Find Molecular “Switch” to Prolong Survival

Wilmot Cancer Institute scientists believe they have figured out why a commonly used drug to treat late-stage prostate cancer stops working after four or five months and appears to have a dual function that later turns the cancer into a relentless aggressor.

Source: University of Rochester Medical Center Press Releases - June 13, 2019 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news